1. Home
  2. NSPR vs MIND Comparison

NSPR vs MIND Comparison

Compare NSPR & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

BUY

Current Price

$0.46

Market Cap

38.9M

Sector

Health Care

ML Signal

BUY

Logo MIND Technology Inc. (DE)

MIND

MIND Technology Inc. (DE)

SELL

Current Price

$4.31

Market Cap

41.2M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
NSPR
MIND
Founded
2005
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
41.2M
IPO Year
2009
1997

Fundamental Metrics

Financial Performance
Metric
NSPR
MIND
Price
$0.46
$4.31
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $3.33
N/A
AVG Volume (30 Days)
★ 108.5K
67.0K
Earning Date
11-03-2026
09-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 29.77
EPS
★ N/A
N/A
Revenue
$2,310,000.00
★ $42,675,000.00
Revenue This Year
$9.14
N/A
Revenue Next Year
$105.44
$73.65
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.46
$3.63
52 Week High
$2.41
$14.50

Technical Indicators

Market Signals
Indicator
NSPR
MIND
Relative Strength Index (RSI) 24.56 49.99
Support Level N/A $4.25
Resistance Level $1.00 $4.78
Average True Range (ATR) 0.08 0.26
MACD -0.01 -0.00
Stochastic Oscillator 2.19 40.71

Price Performance

Historical Comparison
NSPR
MIND

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in single segment namely, Seamap which provides services and products, including engineering, repairs and software licensing, utilized in marine exploration, marine survey and maritime security for marine survey companies, seismic survey contractors, research institutes, non-military government organizations and operators of port facilities and other offshore installations. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

Share on Social Networks: